Global Influences Shaping National Intellectual Property Laws

When a country joins the World Trade Organization, it doesn’t just gain access to global markets – it also signs on to a set of rules that directly reshape its domestic laws. For India, the single most transformative moment in intellectual property law came in 1994 when it became a signatory to the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). What followed was not just a series of legislative tweaks but a fundamental restructuring of how India thinks about innovation, protection, and the rights of creators – all driven by the pressure and promise of global integration.

Why global changes force national IP reform 🔗

Intellectual property has always been territorial – a patent or copyright registered in India traditionally had no automatic standing in the United States or Europe. But as global trade expanded through the late 20th century, this fragmentation became a serious problem for multinational businesses and innovating economies alike. Countries needed a common floor of IP protection so that goods, services, and technologies could cross borders without the constant risk of being freely copied.

This was the core logic behind TRIPS. Negotiated during the Uruguay Round of GATT between 1986 and 1994, the agreement introduced intellectual property law into the multilateral trading system for the first time. It set minimum standards for patents, copyrights, trademarks, geographical indications, and trade secrets that every WTO member was obligated to adopt. For developing nations like India, this was a significant shift – the country had previously designed its IP laws with explicit flexibility to serve domestic public interests, particularly in sectors like pharmaceuticals.

India’s initial resistance and eventual compliance 🔗

India was not a passive or enthusiastic participant in the TRIPS negotiations. The country argued strongly during the talks that a nation’s level of economic development should determine the extent of IP protection it offers. India, along with several other developing nations, pushed for a transition period approach – and successfully secured it. Developing countries were given until 2005 to fully comply, while least-developed countries received even longer timelines.

Despite this, India faced immediate pressure. In 1997, the United States filed a complaint against India at the WTO for failing to establish a system for receiving patent applications in the pharmaceutical sector. This led India to pass the Patents (Amendment) Act, 1999, which added provisions for exclusive marketing rights and allowed applications for product patents in drugs and agrochemicals to be received, even if not yet examined.

The patent law overhaul: from process to product patents 🔗

Before TRIPS, India’s patent regime was deliberately designed to encourage its generic pharmaceutical industry. India did not allow product patents in pharmaceuticals and agrochemicals – only process patents – meaning a domestic manufacturer could legally produce a patented drug simply by using a different manufacturing process. This approach made India the world’s leading supplier of affordable generic medicines.

TRIPS changed this fundamentally. The 2005 Patents (Amendment) Act introduced product patents across all fields of technology, including food, drugs, and chemicals. This was a direct compliance with Article 27 of TRIPS, which prohibits discrimination in the grant of patents across fields of technology. The patent term was also standardized at 20 years from the date of filing, in line with TRIPS requirements.

However, India didn’t simply capitulate to global pressure. The 2005 amendment included a uniquely Indian safeguard: Section 3(d), which prevents the grant of patents for new forms of known substances unless they demonstrate significantly enhanced efficacy. This provision was specifically designed to prevent “evergreening” – the practice of pharmaceutical companies extending patent monopolies through minor, non-innovative modifications to existing drugs.

The constitutional validity of this approach was tested and upheld in the landmark case of Novartis AG v. Union of India (2013), where the Supreme Court denied a patent to the cancer drug Glivec (imatinib mesylate), ruling that the modified salt form of the drug did not demonstrate enhanced therapeutic efficacy. The decision signaled that TRIPS compliance and public health protection are not mutually exclusive.

Copyright law: aligning with the digital age 🔗

India’s Copyright Act, 1957 has been amended multiple times in the post-TRIPS era. The most significant update came through the Copyright (Amendment) Act, 2012, which addressed royalties for authors, introduced compulsory licensing provisions for persons with disabilities, and strengthened protections for the digital environment.

Critically, India has acceded to the WIPO Copyright Treaty (WCT) and the WIPO Performances and Phonograms Treaty (WPPT), both of which extend copyright protection to the internet and digital sphere. These treaties were a direct response to the challenges posed by digital reproduction and online distribution of creative works – something that the original TRIPS framework from 1995 had not fully anticipated. For Indian musicians, filmmakers, and authors, this meant stronger protections in an era of streaming and digital piracy.

Trademark and design law: brand protection in a globalized economy 🔗

The Trade Marks Act, 1999 replaced India’s older Trade and Merchandise Marks Act, 1958, and brought Indian trademark law fully in line with TRIPS obligations. It introduced service marks, collective marks, and certification marks as protectable categories, and established a more robust system of opposition and cancellation proceedings. The 2017 Trade Marks Rules further simplified and digitized the registration process.

Similarly, the Designs Act, 2000 replaced the century-old Designs Act of 1911, aligning with Article 25 of TRIPS. It extended protection to 10 years, extendable to 15, and introduced a faster and more streamlined registration process – important for industries like textiles, handicrafts, and automotive components where design innovation is commercially significant.

Geographical indications: protecting India’s heritage products 🔗

One of the more India-specific outcomes of TRIPS compliance was the enactment of the Geographical Indications of Goods (Registration and Protection) Act, 1999. Articles 22-24 of TRIPS mandate protection for geographical indications, and India responded with a dedicated law that has since protected products like Darjeeling Tea, Basmati Rice, Kanjeevaram Silk, and Kolkata Rosogolla from misuse and misrepresentation in international markets.

GI protection serves a dual function: it preserves the cultural and artisanal heritage of specific communities while also providing significant commercial leverage in export markets. An Indian producer of Darjeeling Tea, for instance, can take legal action against foreign manufacturers who falsely brand their product with the same name.

Plant varieties: a sui generis approach to agriculture 🔗

Article 27.3(b) of TRIPS requires member countries to provide protection for plant varieties, either through patents or through an effective sui generis system. India chose the latter route, enacting the Protection of Plant Varieties and Farmers’ Rights (PPV&FR) Act, 2001. What makes India’s approach distinctive is its dual focus: the law protects the commercial rights of plant breeders while simultaneously recognizing farmers as breeders and conservers of genetic resources – a balance that purely patent-based systems do not offer.

The National IPR Policy, 2016: a unified vision 🔗

While the individual legislative amendments brought India into TRIPS compliance, the country still lacked a cohesive national framework. Before 2016, India’s IP regime was fragmented across multiple ministries and departments, creating administrative inefficiencies and gaps in enforcement. India’s ranking of 81st in the Global Innovation Index in 2015 underscored the urgency for systemic reform.

The National IPR Policy, adopted on May 12, 2016, addressed this by bringing all forms of IP – patents, trademarks, copyrights, designs, geographical indications, semiconductor integrated circuit layout designs, trade secrets, and plant varieties – under a single vision document. The policy’s mission, “Creative India; Innovative India,” set the tone for a shift from mere compliance to proactive IP generation.

Key outcomes of the policy include substantial fee reductions of 80% for patents and 75% for designs for startups and MSMEs, the establishment of the Cell for IPR Promotion and Management (CIPAM) under DPIIT as the nodal implementation body, and the integration of IPR education into the NCERT Commerce curriculum. IP filings from Indian citizens increased by 44% between 2020-21 and 2024-25, and India’s Global Innovation Index rank improved from 81st in 2015 to 40th in 2023.

Enforcement: strengthening the compliance machinery 🔗

Compliance with TRIPS is not just about having the right laws on paper – it requires functional enforcement mechanisms. India has progressively strengthened these. The Customs Act of 1962 was amended, and the Intellectual Property Rights (Imported Goods) Enforcement Rules, 2007 were enacted to allow customs authorities to seize infringing goods at the border. Civil remedies under IP laws were expanded to include enhanced damages for infringement and injunctions. The IP offices have also modernized their operations – processing times for patent applications were projected to reduce from around 48 months to 24-30 months in line with TRIPS efficiency principles.

The broader significance: balancing global obligations with domestic needs 🔗

India’s journey from a cautious TRIPS opponent to a TRIPS-compliant innovating economy illustrates a broader truth about global IP governance: international agreements set the floor, but they don’t dictate the entire architecture of a national IP system. Countries retain considerable flexibility in how they implement minimum standards, as tools like compulsory licensing, Section 3(d)-type provisions, and sui generis plant variety systems demonstrate.

For India specifically, the post-TRIPS era has meant walking a careful line – protecting the interests of innovators and attracting foreign investment on one side, and safeguarding public access to medicines, agricultural resources, and traditional knowledge on the other. The ongoing challenge is not just legislative but interpretive: how courts, regulators, and policymakers apply the law in specific cases will continue to shape where exactly India stands in the global IP order.

What do you think? India’s Section 3(d) is often cited as a model for how developing countries can comply with TRIPS while protecting public health – do you think other developing nations should adopt similar provisions in their patent laws? And as digital technology keeps evolving, should TRIPS itself be renegotiated to address areas like artificial intelligence-generated works and data protection?

References

1. https://www.wto.org/english/tratop_e/trips_e/trips_e.htm
2. https://en.wikipedia.org/wiki/TRIPS_Agreement
3. https://blog.ipleaders.in/patent-laws-india-compliance-trips-agreement/
4. https://kanoonpedia.com/intellectual-property-rights-post-trips-agreement/
5. https://www.legalserviceindia.com/legal/article-10867-the-impact-of-the-trips-agreement-on-indian-ip-laws-and-their-implementation.html
6. https://www.pib.gov.in/Pressreleaseshare.aspx?PRID=1557418
7. https://www.pmfias.com/ipr-intellectual-property-rights/
8. https://cplan.in/indias-national-intellectual-property-rights-policy-a-comprehensive-framework-for-innovation-and-development/
9. https://www.drishtiias.com/daily-updates/daily-news-analysis/national-ipr-policy
10. https://aroojlaw.com/kb/the-trips-agreement-and-its-impact-on-intellectual-property-laws-in-india/